Process Development Engineer (Compounding & Coating) | Process Development Engineer* Compounding & Coating - Roche Mannheim

Franz & Wach Personalservice PEN

Mannheim, Baden-Württemberg, Deutschland
Published May 7, 2026
Full-time
Fixed-term

Job Summary

As a Process Development Engineer at Roche Diagnostics, you will play a critical role in the development and optimization of compounding and coating processes for disposable medical products. Your day-to-day responsibilities include planning and executing technical tasks in the laboratory and technical center, designing and optimizing batch processes, and conducting analytical characterization of development samples. You will be responsible for maintaining technical equipment, ensuring compliance with safety and quality standards, and documenting all experimental results in accordance with SOPs. This position requires a strong technical background in process engineering or chemical engineering, with a focus on method development and process scale-up. You will work in a cross-functional environment, coordinating technical work packages and presenting findings to internal stakeholders. This role offers the unique opportunity to work within a leading pharmaceutical environment, with a strong focus on professional growth and potential long-term integration into the Roche team.

Required Skills

Education

Bachelor's degree in Process Engineering, Chemical Engineering, or a comparable field; alternatively, a completed advanced technical training (Techniker)

Experience

  • Minimum 3 years of professional experience as a Chemical Development Engineer or Technician
  • Profound experience in process and product development for web and batch processes
  • Experience in preparation and application procedures
  • Experience in developing and creating manufacturing and experimental documentation

Languages

English (Fluent)

Additional

  • Must be eligible to work in Germany. Position is a temporary contract (Arbeitnehmerüberlassung) via Franz & Wach with the aim of potential transition to Roche.